Zhang S, Yao K, Pi Y, Yang S, Huang Z, Pan X
Discov Oncol. 2024; 15(1):827.
PMID: 39714552
PMC: 11666847.
DOI: 10.1007/s12672-024-01729-z.
Qi Y, Rezaeian A, Wang J, Huang D, Chen H, Inuzuka H
Biochim Biophys Acta Rev Cancer. 2024; 1879(5):189140.
PMID: 38909632
PMC: 11390337.
DOI: 10.1016/j.bbcan.2024.189140.
Yang Y, Xie Q, Hu C, Xu J, Chen L, Li Y
Int J Med Sci. 2024; 21(8):1575-1588.
PMID: 38903918
PMC: 11186432.
DOI: 10.7150/ijms.91584.
Wani T, Zargar S
Cells. 2023; 12(8).
PMID: 37190029
PMC: 10136799.
DOI: 10.3390/cells12081120.
Sampson C, Wang Q, Otkur W, Zhao H, Lu Y, Liu X
Clin Transl Med. 2023; 13(3):e1204.
PMID: 36881608
PMC: 9991012.
DOI: 10.1002/ctm2.1204.
Identify Biomarkers and Design Effective Multi-Target Drugs in Ovarian Cancer: Hit Network-Target Sets Model Optimizing.
Esmaeilzadeh A, Kashian M, Mahmood Salman H, Alsaffar M, Musa Jaber M, Soltani S
Biology (Basel). 2022; 11(12).
PMID: 36552360
PMC: 9776135.
DOI: 10.3390/biology11121851.
F-box only protein 9 and its role in cancer.
Hussain S, Dong J, Ma X, Li J, Chen S, Clement A
Mol Biol Rep. 2022; 49(2):1537-1544.
PMID: 35025031
DOI: 10.1007/s11033-021-07057-7.
Discriminative SKP2 Interactions with CDK-Cyclin Complexes Support a Cyclin A-Specific Role in p27KIP1 Degradation.
Salamina M, Montefiore B, Liu M, Wood D, Heath R, Ault J
J Mol Biol. 2021; 433(5):166795.
PMID: 33422522
PMC: 7895821.
DOI: 10.1016/j.jmb.2020.166795.
Transcriptome Analysis of Ovarian and Uterine Clear Cell Malignancies.
Alldredge J, Randall L, De Robles G, Agrawal A, Mercola D, Liu M
Front Oncol. 2021; 10:598579.
PMID: 33415077
PMC: 7784081.
DOI: 10.3389/fonc.2020.598579.
A cell competition-based small molecule screen identifies a novel compound that induces dual c-Myc depletion and p53 activation.
Tadele D, Robertson J, Crispin R, Herrera M, Chlubnova M, Piechaczyk L
J Biol Chem. 2020; 296:100179.
PMID: 33303632
PMC: 7948465.
DOI: 10.1074/jbc.RA120.015285.
The Role of Cullin-RING Ligases in Striated Muscle Development, Function, and Disease.
Blondelle J, Biju A, Lange S
Int J Mol Sci. 2020; 21(21).
PMID: 33114658
PMC: 7672578.
DOI: 10.3390/ijms21217936.
Regulation of Epithelial-Mesenchymal Plasticity by the E3 Ubiquitin-Ligases in Cancer.
Rodriguez-Alonso A, Casas-Pais A, Roca-Lema D, Grana B, Romay G, Figueroa A
Cancers (Basel). 2020; 12(11).
PMID: 33114139
PMC: 7690828.
DOI: 10.3390/cancers12113093.
Recent advances in the development of protein-protein interactions modulators: mechanisms and clinical trials.
Lu H, Zhou Q, He J, Jiang Z, Peng C, Tong R
Signal Transduct Target Ther. 2020; 5(1):213.
PMID: 32968059
PMC: 7511340.
DOI: 10.1038/s41392-020-00315-3.
Epigenetic silencing of the ubiquitin ligase subunit FBXL7 impairs c-SRC degradation and promotes epithelial-to-mesenchymal transition and metastasis.
Moro L, Simoneschi D, Kurz E, Arbini A, Jang S, Guaragnella N
Nat Cell Biol. 2020; 22(9):1130-1142.
PMID: 32839549
PMC: 7484425.
DOI: 10.1038/s41556-020-0560-6.
The F-box protein FBXL16 up-regulates the stability of C-MYC oncoprotein by antagonizing the activity of the F-box protein FBW7.
Morel M, Shah K, Long W
J Biol Chem. 2020; 295(23):7970-7980.
PMID: 32345600
PMC: 7278360.
DOI: 10.1074/jbc.RA120.012658.
DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation.
Cui H, Wang Q, Lei Z, Feng M, Zhao Z, Wang Y
J Exp Clin Cancer Res. 2019; 38(1):350.
PMID: 31409387
PMC: 6693180.
DOI: 10.1186/s13046-019-1358-x.
SCF(FBXW7)-mediated degradation of p53 promotes cell recovery after UV-induced DNA damage.
Galindo-Moreno M, Giraldez S, Limon-Mortes M, Belmonte-Fernandez A, Reed S, Saez C
FASEB J. 2019; 33(10):11420-11430.
PMID: 31337255
PMC: 6766643.
DOI: 10.1096/fj.201900885R.
FBXO22 Suppresses Metastasis in Human Renal Cell Carcinoma via Inhibiting MMP-9-Mediated Migration and Invasion and VEGF-Mediated Angiogenesis.
Guo F, Liu J, Han X, Zhang X, Lin T, Wang Y
Int J Biol Sci. 2019; 15(3):647-656.
PMID: 30745851
PMC: 6367582.
DOI: 10.7150/ijbs.31293.
F-box protein FBXO16 functions as a tumor suppressor by attenuating nuclear β-catenin function.
Paul D, Islam S, Manne R, Dinesh U, Malonia S, Maity B
J Pathol. 2019; 248(3):266-279.
PMID: 30714168
PMC: 6619347.
DOI: 10.1002/path.5252.
FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.
Cui Y, Kim H, Lee M, Yi J, Kim R, Uddin N
Oncogene. 2018; 37(43):5794-5809.
PMID: 29973690
DOI: 10.1038/s41388-018-0372-3.